Showing results (81-90 of 721) with videos related to
Sort By:
Pageof 73
Journal of Parkinson'S Disease|March 12, 2014
An update of the impact of deep brain stimulation on non motor symptoms in Parkinson's diseaseLisa Klingelhoefer, Michael Samuel, K Ray Chaudhuri, et al.Journal of Medical Economics|May 20, 2022
Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's diseaseK Ray Chaudhuri, Annette Hand, Fallon Obam, et al.Journal of Parkinson'S Disease|February 1, 2021
How Time Rules: Diurnal Motor Patterns in de novo Parkinson's DiseaseDaniel J van Wamelen, Daniele Urso, K Ray ChaudhuriExpert Opinion on Drug Safety|October 18, 2019
Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An updateValentina Leta, Peter Jenner, K Ray Chaudhuri, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|December 22, 2017
Two-hundred Years Later: Is Parkinson's Disease a Single Defined Entity?Mayela Rodríguez-Violante, Amin Cervantes-Arriaga, Stanley Fahn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 4, 2015
Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson's diseaseTuhin Virmani, Carol B Moskowitz, Jean-Paul Vonsattel, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutationMelissa J Nirenberg, Jenny Libien, Jean-Paul Vonsattel, et al.Journal of Integrative Neuroscience|January 8, 2022
Pain in neurodegenerative diseases with atypical parkinsonism: a systematic review on prevalence, clinical presentation, and findings from experimental studiesJerry Yi Chang, Katarina Rukavina, Timothy Lawn, et al.Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 25, 2002
Observations on haematological and cardiovascular effects of erythropoietin treatment in multiple system atrophy with sympathetic failureAndrea Sylvia Winkler, Sabine Landau, Peter Watkins, et al.Journal of Medical Economics|April 28, 2026
Subcutaneous foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's disease (aPD): societal cost impact analysis for the UK, France, Germany, Spain, and CanadaK Ray Chaudhuri, Juan Carlos Parra, Trishal Boodhna, et al.Pageof 73